Insperity (NSP) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
31 Oct, 2025Executive summary
Q2 2025 saw a 1% increase in average paid worksite employees to 309,115, but net income and EPS dropped sharply, with adjusted EBITDA down 52% to $32 million and adjusted EPS at $0.26, both below guidance due to higher benefits costs.
Gross profit per worksite employee declined to $240/month from $282/month in Q2 2024, mainly due to unfavorable healthcare claims and higher pharmacy costs.
Strategic partnership with Workday is progressing, with Insperity HRScale beta launch targeted for early 2026 and a multi-phase client rollout planned.
Management remains confident in accelerated growth and improved profitability in 2026, driven by pricing, plan design changes, and expense management.
New HR solutions portfolio launched, including Insperity HR360, HRCore, and HRScale.
Financial highlights
Q2 2025 revenue increased 3% year-over-year to $1.66 billion, but gross profit fell 14% to $223 million due to elevated benefits costs.
Operating expenses decreased 3% year-over-year, with $14 million invested in the Workday partnership in Q2.
YTD adjusted EBITDA was $134 million, down 36%, and adjusted EPS was $1.83, down 42% versus prior year.
$64 million returned to shareholders in H1 2025 via dividends ($45 million) and share repurchases ($19 million).
Adjusted cash at June 30, 2025 was $114 million, with $280 million available under credit facility.
Outlook and guidance
Full-year 2025 adjusted EBITDA guidance is $170–$205 million, down 37–24% year-over-year; adjusted EPS guidance is $1.81–$2.51, down 49–30% year-over-year.
2025 worksite employee growth forecasted at 1%-2% over 2024.
Full-year benefits cost per employee guidance raised by 75-100 basis points due to persistent cost pressures.
Q3 2025 guidance: 1%-2% worksite employee growth, adjusted EBITDA of $24-$44 million, and adjusted EPS of $0.06-$0.49.
Management expects improved profitability in 2026, citing recent growth momentum and strategic initiatives.
Latest events from Insperity
- 2026 guidance targets margin recovery and growth, led by HRScale and cost controls.NSP
Q4 202513 Feb 2026 - Q2 2024 adjusted EPS up 34%, but 2024 guidance signals lower WSEEs and earnings.NSP
Q2 20242 Feb 2026 - Q3 net income and EPS dropped sharply, with full-year adjusted EPS guided at $3.42–$3.66.NSP
Q3 202417 Jan 2026 - Higher healthcare costs and economic uncertainty drove lower Q1 earnings despite revenue growth.NSP
Q1 202524 Dec 2025 - 2024 results showed resilient profitability, strong retention, and growth momentum for 2025.NSP
Q4 20249 Dec 2025 - Annual Meeting to vote on directors, pay, incentive plan amendment, and auditor ratification.NSP
Proxy Filing1 Dec 2025 - Q3 revenue up 4% but net loss and EBITDA fell on higher costs; 2026 recovery expected.NSP
Q3 202513 Nov 2025